{'fraction_non_alphanumeric': 0.045335658238884045, 'fraction_numerical': 0.023539668700959023, 'mean_word_length': 5.56, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Smad6 Suppresses the Growth and Self‐Renewal of Hepatic Progenitor Cells

Activation of hepatic progenitor cells (HPCs) is commonly observed in chronic liver disease and Wnt/β‐catenin signaling plays a crucial role in the expansion of HPCs. However, the molecular mechanisms that regulate the activation of Wnt/β‐catenin signaling in the liver, especially in HPCs, remain largely elusive. Here, we reported that ectopic expression of Smad6 suppressed the proliferation and self‐renewal of WB‐F344 cells, a HPC cell line. Mechanistically, we found that Smad6 inhibited Wnt/β‐catenin signaling through promoting the interaction of C‐terminal binding protein (CtBP) with β‐catenin/T‐cell factor (TCF) complex to inhibit β‐catenin mediated transcriptional activation in WB‐F344 cells. We used siRNA targeting β‐catenin to demonstrate that Wnt/β‐catenin signaling was required for the proliferation and self‐renewal of HPCs. Taken together, these results suggest that Smad6 is a regulatory molecule which regulates the proliferation, self‐renewal and Wnt/β‐catenin signaling in HPCs. J. Cell. Physiol. 229: 651–660, 2014. © 2013 Wiley Periodicals, Inc.